[Low-molecular dextran (40,000) in the treatment of scleroderma].
D003911:Dextrans / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008970:Molecular Weight; D012594:Scleroderma, Localized / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000188:drug therapy*
D003911:Dextrans
Dextran niskoczasteczkowy (40 tys.) w leczeniu twardziny